Data

VERBATIM: A randomised controlled trial of aripiprazole for the treatment of auditory verbal hallucinations in borderline personality disorder

Health Data Australia Contributor Records
Chanen, Andrew ; Mental Health Node
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.26187/RS16-J444&rft.title=VERBATIM: A randomised controlled trial of aripiprazole for the treatment of auditory verbal hallucinations in borderline personality disorder&rft.identifier=http://doi.org/10.26187/RS16-J444&rft.publisher=Orygen&rft.description=This dataset originates from a 12-week, single-centre, randomized controlled trial (RCT) that examines the efficacy of aripiprazole versus placebo in treating auditory verbal hallucinations (AVHs) in 15-25 year-olds diagnosed with Borderline Personality Disorder (BPD). The study addresses a critical gap in clinical practice by testing conventional pharmacotherapy used for AVHs in schizophrenia, applied to similar symptoms in BPD, a practice not currently supported by NHMRC guidelines for BPD treatment. Participants were followed for a total of 27 weeks, with assessments on AVH severity, BPD symptoms, general psychopathology, functioning, and the experience of psychotic symptoms. The study also explored changes in the neurobiological mechanisms underlying AVHs as influenced by treatment.&rft.creator=Chanen, Andrew &rft.creator=Mental Health Node &rft.date=2022&rft.relation=www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12616001192471&rft_subject=FOR: Mental Health&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Full description

This dataset originates from a 12-week, single-centre, randomized controlled trial (RCT) that examines the efficacy of aripiprazole versus placebo in treating auditory verbal hallucinations (AVHs) in 15-25 year-olds diagnosed with Borderline Personality Disorder (BPD). The study addresses a critical gap in clinical practice by testing conventional pharmacotherapy used for AVHs in schizophrenia, applied to similar symptoms in BPD, a practice not currently supported by NHMRC guidelines for BPD treatment. Participants were followed for a total of 27 weeks, with assessments on AVH severity, BPD symptoms, general psychopathology, functioning, and the experience of psychotic symptoms. The study also explored changes in the neurobiological mechanisms underlying AVHs as influenced by treatment.

Notes

HeSANDA 1.0.0

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Publications

  • References VERBATIM: A randomised controlled trial of aripiprazole for the treatment of auditory verbal hallucinations in borderline personality disorder
    local : www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12616001192471

Related People

Subjects
FOR: Mental Health |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Identifiers